BS

Budiyar Sachidanand Rai

Active Director Managing Director DIN 00151145
DIN 00151145 First appointment Sep 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Sep 2000
Shareholding value •••• Premium profile

About Budiyar Sachidanand Rai

Data last updated:

Budiyar Sachidanand Rai is a Managing Director at Srk Life Sciences & Research (India) Private Limited (since 2013), Managing Director at Octaplus Medicare Solutions Private Limited (since 2016) and Director at Swasthayana Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Tourism And Accommodation. The 4 current companies with reported revenue have a combined latest revenue of ₹3.18 Cr; the largest is Srk Life Sciences & Research (India) Private Limited at ₹2.67 Cr (FY 2024).

DIN 00151145
Primary Designation Managing Director
Industry Pharma
First Appointment 15 Sep 2000
Oldest Company Age 33 yrs
Largest company Srk Life Sciences & Research (India) Private Limited · ₹2.67 Cr (FY 2024)
Combined revenue ₹3.18 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director17 Jul 20132013₹2.67 Cr (FY 2024)Active
Managing Director24 Mar 20162016₹44 Lakh (FY 2017)Active
Swasthayana Private Limited U85110KA2022PTC161244
Director13 May 20222022₹6.7 Lakh (FY 2024)Active
Dakkan Park Private Limited U55101KA1993PTC014446
Director15 Sep 20001993₹78,554 (FY 2025)Active
Marine Genics Foods Private Limited U15135KA2022PTC168239
Director23 Nov 20222022Active

Directorship timeline

Open interactive timeline →
Dakkan Park Private Limited
Octaplus Medicare Solutions Private Limited
Srk Life Sciences & Research (India) Private Limited
Swasthayana Private Limited
Premium access

Shareholding and investment profile for Budiyar Sachidanand Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Budiyar Sachidanand Rai

Budiyar Sachidanand Rai currently holds 5 directorships: Srk Life Sciences & Research (India) Private Limited (Managing Director, since 17 Jul 2013, revenue ₹2.67 Cr (FY 2024)); Octaplus Medicare Solutions Private Limited (Managing Director, since 24 Mar 2016, revenue ₹44 Lakh (FY 2017)); Swasthayana Private Limited (Director, since 13 May 2022, revenue ₹6.7 Lakh (FY 2024)); Dakkan Park Private Limited (Director, since 15 Sep 2000, revenue ₹78,554 (FY 2025)); Marine Genics Foods Private Limited (Director, since 23 Nov 2022).

Budiyar Sachidanand Rai was first appointed on 15 Sep 2000 as Director at Dakkan Park Private Limited. The most recent appointment on record is 23 Nov 2022 at Marine Genics Foods Private Limited.

The 4 current companies of Budiyar Sachidanand Rai that report revenue have a combined latest revenue of ₹3.18 Cr: Srk Life Sciences & Research (India) Private Limited ₹2.67 Cr (FY 2024); Octaplus Medicare Solutions Private Limited ₹44 Lakh (FY 2017); Swasthayana Private Limited ₹6.7 Lakh (FY 2024); Dakkan Park Private Limited ₹78,554 (FY 2025).

The current boards of Budiyar Sachidanand Rai's companies include Humchadakatte Gopalaiah Malathesh (Srk Life Sciences & Research (India) Private Limited), Kartikeya Vyas Uchila (Srk Life Sciences & Research (India) Private Limited), Rajkumar Janakiraman (Srk Life Sciences & Research (India) Private Limited), Rithesh Rai (Srk Life Sciences & Research (India) Private Limited), Sanjay Kumar Shahri (Srk Life Sciences & Research (India) Private Limited), Rakshan Mogarody Melanta (Octaplus Medicare Solutions Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available